Lonsurf (trifluridine/tipiracil) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More
oncodaily.com/drugs/lonsur...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Lonsurf #GEJC #GastricCancer #GIOnc
oncodaily.com/drugs/lonsur...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Lonsurf #GEJC #GastricCancer #GIOnc
Lonsurf (trifluridine/tipiracil) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily
Lonsurf (trifluridine/tipiracil) is approved to treat gastric/ GEJ and CRC cancers. This article explores its uses , side effects, dosage, expectations.
oncodaily.com
August 24, 2025 at 9:59 PM
Lonsurf (trifluridine/tipiracil) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More
oncodaily.com/drugs/lonsur...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Lonsurf #GEJC #GastricCancer #GIOnc
oncodaily.com/drugs/lonsur...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Lonsurf #GEJC #GastricCancer #GIOnc
Lonsurf sehe ich direkt vor mir
December 20, 2025 at 11:36 PM
Lonsurf sehe ich direkt vor mir
Vielleicht werd ich alt, aber ich komm bei diesen ganzen neuen Pokemon nicht mehr mit.
![[...] AOK Nordost. Man kann sich vorstellen, welchen finanziellen Schaden Rezeptfälscher der Gesamtgemeinschaft der gesetzlich Krankenversicherten jährlich zufügen.“ Die größten finanziellen Verluste sind auf Fälschungen von Alecensa, Braftovi, Caprelsa, Fentanyl, Lenvima, Lonsurf, Mekinist, Mektovi, Mounjaro, Orserdu, Ozempic, Ragwizax und Tukysa zurückzuführen.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:5lktscfkgkg7kek57czn74pc/bafkreiawg6jvvs6aorfzgfxz4bdciudpilarwuuew3vvb7u7fpmf2mmobe)
December 20, 2025 at 11:33 PM
Vielleicht werd ich alt, aber ich komm bei diesen ganzen neuen Pokemon nicht mehr mit.
the last month of scrambling to get back into treatment has been chaotic and starting chemo again has indeed been difficult but, it’s hard to not be excited about taking pills when your pillboxes are this rad:
August 6, 2026 at 2:55 PM
the last month of scrambling to get back into treatment has been chaotic and starting chemo again has indeed been difficult but, it’s hard to not be excited about taking pills when your pillboxes are this rad:
Also while the rates grow, people live longer with cancer requiring longer durations of treatment. Someone who would have died with in 6-12 months may live another 3 years of Fruzaqla or Lonsurf.
June 5, 2025 at 2:38 PM
Also while the rates grow, people live longer with cancer requiring longer durations of treatment. Someone who would have died with in 6-12 months may live another 3 years of Fruzaqla or Lonsurf.
well, things are looking up! and folks that is bad news lol
updated bloodwork after one round of Lonsurf. hopefully we'll see some impact from the 2nd round, which i'm currently in the middle of. i have a CT scan on Friday and we go from there.
updated bloodwork after one round of Lonsurf. hopefully we'll see some impact from the 2nd round, which i'm currently in the middle of. i have a CT scan on Friday and we go from there.
September 20, 2026 at 2:44 PM
well, things are looking up! and folks that is bad news lol
updated bloodwork after one round of Lonsurf. hopefully we'll see some impact from the 2nd round, which i'm currently in the middle of. i have a CT scan on Friday and we go from there.
updated bloodwork after one round of Lonsurf. hopefully we'll see some impact from the 2nd round, which i'm currently in the middle of. i have a CT scan on Friday and we go from there.
The new stuff (if it's what they ultimately decide on) is called Lonsurf.
I hate changing again so soon though. Feels like I'm just eliminating my options and there's gonna come a point where I don't have any options left. Or like it's becoming less effective. 'Cuz it is, your body gets used to it.
I hate changing again so soon though. Feels like I'm just eliminating my options and there's gonna come a point where I don't have any options left. Or like it's becoming less effective. 'Cuz it is, your body gets used to it.
August 18, 2026 at 5:30 PM
The new stuff (if it's what they ultimately decide on) is called Lonsurf.
I hate changing again so soon though. Feels like I'm just eliminating my options and there's gonna come a point where I don't have any options left. Or like it's becoming less effective. 'Cuz it is, your body gets used to it.
I hate changing again so soon though. Feels like I'm just eliminating my options and there's gonna come a point where I don't have any options left. Or like it's becoming less effective. 'Cuz it is, your body gets used to it.
Thank you. I’m on Lonsurf and Avastin at present. Last scans two months ago showed a little bit of shrinkage to primary and secondaries. Is that going to continue? Treatment is allowing me to function mostly but the fatigue is constant.
April 28, 2025 at 4:51 PM
Thank you. I’m on Lonsurf and Avastin at present. Last scans two months ago showed a little bit of shrinkage to primary and secondaries. Is that going to continue? Treatment is allowing me to function mostly but the fatigue is constant.
Lonsurf (Trifluridina + Tipiracilo) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento
Saiba mais em:
🔗 swki.me/q7US3nHk
#infarmed #medicamentos #financiamentopúblico
#lonsurf
Saiba mais em:
🔗 swki.me/q7US3nHk
#infarmed #medicamentos #financiamentopúblico
#lonsurf
Lonsurf (Trifluridina + Tipiracilo) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento
Infarmed
swki.me
November 18, 2025 at 2:45 PM
Lonsurf (Trifluridina + Tipiracilo) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento
Saiba mais em:
🔗 swki.me/q7US3nHk
#infarmed #medicamentos #financiamentopúblico
#lonsurf
Saiba mais em:
🔗 swki.me/q7US3nHk
#infarmed #medicamentos #financiamentopúblico
#lonsurf
Taiho Pharma Co. v. MSN Labs Private Ltd.
Taiho Pharma Co. v. MSN Labs Private Ltd.
Lonsurf® (tipiracil) - Case Name: Taiho Pharma Co. v. MSN Labs Private Ltd., No. 19-2342-JLH (D. Del. Jan. 23, 2025) (Hall, J.) Drug Product and...
www.jdsupra.com
May 1, 2025 at 3:31 AM
Taiho Pharma Co. v. MSN Labs Private Ltd.
Feed: "Oncodaily | Oncology News, Insights, Stories"
Published on Sunday, August 24, 2025
Published on Sunday, August 24, 2025
Lonsurf (trifluridine/tipiracil) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Lonsurf (trifluridine/tipiracil) is approved to treat gastric/ GEJ and CRC cancers. This article explores its uses , side effects, dosage, expectations.
oncodaily.com
August 24, 2025 at 9:33 AM
Feed: "Oncodaily | Oncology News, Insights, Stories"
Published on Sunday, August 24, 2025
Published on Sunday, August 24, 2025
Otsuka Holdings Co.'s Taiho unit and MSN Laboratories Private Ltd. agreed to end a lawsuit over the validity of two patents MSN Labs had conceded that its copy of the cancer drug Lonsurf infringes, three weeks after a federal judge nixed a bench trial.
Otsuka, MSN Labs End Patent Suit Over Lonsurf Cancer Drug Copy
Otsuka Holdings Co.'s Taiho unit and MSN Laboratories Private Ltd. agreed to end a lawsuit over the validity of two patents MSN Labs had conceded that its copy of the cancer drug Lonsurf infringes, three weeks after a federal judge nixed a bench trial.
bit.ly
April 22, 2026 at 8:00 AM
Otsuka Holdings Co.'s Taiho unit and MSN Laboratories Private Ltd. agreed to end a lawsuit over the validity of two patents MSN Labs had conceded that its copy of the cancer drug Lonsurf infringes, three weeks after a federal judge nixed a bench trial.
Taiho Oncology Reveals LONSURF's Real-World Effectiveness at ASCO Symposium in 2025#United_States#San_Francisco#Taiho_Oncology#Colorectal_Cancer#LONSURF
Taiho Oncology Reveals LONSURF's Real-World Effectiveness at ASCO Symposium in 2025
Taiho Oncology presented significant real-world findings on LONSURF® at the ASCO Gastrointestinal Cancers Symposium 2025, highlighting its effectiveness in metastatic colorectal cancer treatment.
third-news.com
January 24, 2025 at 11:03 PM
Taiho Oncology Reveals LONSURF's Real-World Effectiveness at ASCO Symposium in 2025#United_States#San_Francisco#Taiho_Oncology#Colorectal_Cancer#LONSURF
#UKOncologyForum
Frequitinib trying hard to find a 3L position. But I'm struggling to justify it's use 3L when evidence is better than placebo yet we have Lonsurf-Beva as SoC now.
It's the problem of trials working in isolation
Frequitinib trying hard to find a 3L position. But I'm struggling to justify it's use 3L when evidence is better than placebo yet we have Lonsurf-Beva as SoC now.
It's the problem of trials working in isolation
June 12, 2025 at 10:27 AM
#UKOncologyForum
Frequitinib trying hard to find a 3L position. But I'm struggling to justify it's use 3L when evidence is better than placebo yet we have Lonsurf-Beva as SoC now.
It's the problem of trials working in isolation
Frequitinib trying hard to find a 3L position. But I'm struggling to justify it's use 3L when evidence is better than placebo yet we have Lonsurf-Beva as SoC now.
It's the problem of trials working in isolation